Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

8049.HK

Strong BuyFull HouseREMOVE

Jilin Province Huinan Changlong Bio-pharmacy Company Limited · Healthcare · Hong Kong · $168M · Avg Vol: $13K/d

100
StockRank
Get insider-trade alerts
Q
79
V
96
M
75
P/E (TTM)
5.1x
ROE
12.3%
D/E
0.0x
Dividend %
12.2%
Dir. Trades · 180d
None →
Buybacks · 180d
None →
AI CONVICTION THESIS

Generic pharmaceutical and beverage manufacturing does not offer the 'un-copyable moat' or 'long reinvestment runway' required for a concentrated fund focused on quality compounders.

COMPANY DESCRIPTION

Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People's Republic of China.

FINANCIAL SUMMARY (HKD)

Year2022202320242025CAGRTTM
Revenue985.4M985.4M1.0B1.1B2.3%1.0B
EPS (HKD)1.311.011.251.350.9%0.46
Shares172.5M172.5M172.5M172.5M0.0%172.5M
Debt0.5M94.1M84.8M0.5M0.0%1.1M
Equity1.9B1.7B1.9B2.0B1.5%—
Op CF238.9M369.9M257.2M366.8M15.4%365.5M
Inv CF-138.1M127.7M-364.1M-268.4M——
Fin CF-32.5M-218.3M-29.3M-207.0M——
Loading 1Y...
PRICE (1Y)+0.7%
0.290.290.290.300.30Jul 31Aug 21Sep 10
SMA 50SMA 200

Close
$0.2939
RSI (14)
35.3
52W High
$0.3416
From 52W High
0.9%

SCORE BREAKDOWN

Quality
79
ROIC
15.4%83.9
ROE
12.3%76.7
GP/Assets
28.5%61.2
Op. Margin
34.9%94.7
FCF/Assets
11.7%89.6
Piotroski
790.5
Int. Cover
50.0x89.2
D/E Ratio
0.00x94.8
Current Ratio
1.47x25.6
Value
96
P/E (TTM)
5.1x97.6
EV/EBITDA
1.3x98.8
P/FCF
3.6x96.0
P/B
0.5x96.5
P/S
1.3x79.7
Div Yield
12.2%99.5
Momentum
75
52W High %
86%78.1
RS 6M
24%83.0
SMA 50/200
1.10x76.3
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
19%54.7

FUNDAMENTALS

Market Cap
$168M
P/E (Forward)
—
Gross Margin
84.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 8049.HK are excluded.

TickerCompanyMkt CapStockRankSignal
8049.HKJilin Province Huinan Changlong Bio-pharmacy Company Limited(you)$168M100Strong Buy
2348.HKDawnrays Pharmaceutical (Holdings) Limited$192M99Strong Buy
3839.HKCPBIO Holding Company Limited$270M96Strong Buy
2161.HKJBM (Healthcare) Limited$192M86Strong Buy
2633.HKJacobson Pharma Corporation Limited$267M90Strong Buy
0950.HKLee's Pharmaceutical Holdings Limited$101M78Buy
3613.HKBeijing Tong Ren Tang Chinese Medicine Company Limited$694M91Strong Buy
2005.HKSSY Group Limited$994M82Strong Buy
3320.HKChina Resources Pharmaceutical Group Limited$3.7B92Strong Buy
0570.HKChina Traditional Chinese Medicine Holdings Co. Limited$893M58Hold

Peer medians: ROE 6.0% · P/E 10.9x · Gross margin 38.0%

Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK): Stock Score Summary

Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) has a MoatMap StockRank of 100/100 based on Quality (79/100), Value (96/100), and Momentum (75/100) factor scores. The current signal is STRONG BUY. Generic pharmaceutical and beverage manufacturing does not offer the 'un-copyable moat' or 'long reinvestment runway' required for a concentrated fund focused on quality compounders.

Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People's Republic of China.

Key Financial Metrics

Price$0.29
Market Cap$168M
P/E (TTM)5.11
Price/Book0.53
Return on Equity12.3%
Return on Invested Capital15.4%
Debt/Equity0.00x
Gross Margin84.8%
Operating Margin34.9%
Revenue Growth-0.9%
Dividend Yield12.2%
Free Cash Flow$47M

Jilin Province Huinan Changlong Bio-pharmacy Company Limited operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Hong Kong).

Frequently Asked Questions

What is Jilin Province Huinan Changlong Bio-pharmacy Company Limited’s (8049.HK) StockRank?
MoatMap’s StockRank for Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) is 100/100, with a Strong Buy signal. It is a composite of Quality (79), Value (96), and Momentum (75) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Jilin Province Huinan Changlong Bio-pharmacy Company Limited have an economic moat?
Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) has a Quality factor score of 79/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Jilin Province Huinan Changlong Bio-pharmacy Company Limited a buy, hold, or sell?
MoatMap’s current signal for Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) is Strong Buy, based on a StockRank of 100/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Jilin Province Huinan Changlong Bio-pharmacy Company Limited in?
Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Hong Kong).
Browse all ranked stocks8049.HK deep dive reportAI ChampionsHow we score stocksSense-check another stock